Growth Metrics

Anaptysbio (ANAB) Share-based Compensation (2016 - 2025)

Anaptysbio filings provide 10 years of Share-based Compensation readings, the most recent being $8.5 million for Q4 2025.

  • For the quarter ending Q4 2025, Share-based Compensation rose 3.93% year-over-year to $8.5 million, compared with a TTM value of $36.1 million through Dec 2025, up 5.94%, and an annual FY2025 reading of $36.1 million, up 5.94% over the prior year.
  • Share-based Compensation hit $8.5 million in Q4 2025 for Anaptysbio, down from $9.2 million in the prior quarter.
  • The five-year high for Share-based Compensation was $10.1 million in Q1 2024, with the low at $2.9 million in Q2 2022.
  • Median Share-based Compensation over the past 5 years was $7.6 million (2022), compared with a mean of $6.4 million.
  • The sharpest move saw Share-based Compensation plummeted 31.26% in 2022, then skyrocketed 172.97% in 2024.
  • Year by year, Share-based Compensation stood at $4.0 million in 2021, then surged by 68.05% to $6.7 million in 2022, then increased by 21.33% to $8.1 million in 2023, then grew by 0.9% to $8.2 million in 2024, then increased by 3.93% to $8.5 million in 2025.
  • According to Business Quant data, Share-based Compensation over the past three periods came in at $8.5 million, $9.2 million, and $9.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.